Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Evofem Biosciences to Report Third Quarter 2021 Results and Provide Corporate


PR Newswire | Oct 28, 2021 08:02AM EDT

Update on Monday, November 15, 2021

10/28 07:00 CDT

Evofem Biosciences to Report Third Quarter 2021 Results and Provide Corporate Update on Monday, November 15, 2021-- Conference Call Scheduled for 4:30 p.m. ET -- SAN DIEGO, Oct. 28, 2021

SAN DIEGO, Oct. 28, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) will hold a webcast and conference call to discuss financial results and business highlights for the third quarter ended September 30, 2021 on Monday, November 15, 2021 at 4:30 p.m. ET (1:30 p.m. PT).

The webcast (live and archived) and related slide presentation can be accessed through https://evofem.investorroom.com/2021Q3Results or directly at https://edge.media-server.com/mmc/p/xmw874kh. Please connect to the webcast at least 15 minutes prior to the start of the call to download any software that may be required.

If participating by phone, please dial in approximately 15 minutes prior to the start of the call using (866) 503-5561 (U.S. toll-free) or (253) 336-2965, and referring to conference ID 7464495.

A telephone replay will be available for 24 hours after the call at (855) 859-2056 (U.S.) or (404) 537-3406 (International), conference ID 7464495.

About Evofem BiosciencesEvofem Biosciences, Inc., (NASDAQ: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (chlamydia and gonorrhea). The Company's first FDA-approved product, Phexxi(r) (lactic acid, citric acid and potassium bitartrate), is a hormone-free, on-demand prescription contraceptive vaginal gel. It comes in a box of 12 pre-filled applicators and is applied 0-60 minutes before each act of sex. Learn more at phexxi.com and evofem.com.

Phexxi(r) is a registered trademark of Evofem Biosciences, Inc.

Investor Relations ContactAmy RaskopfEvofem Biosciences, Inc.araskopf@evofem.comMobile: (917) 673-5775

View original content to download multimedia: https://www.prnewswire.com/news-releases/evofem-biosciences-to-report-third-quarter-2021-results-and-provide-corporate-update-on-monday-november-15-2021-301410776.html

SOURCE Evofem Biosciences, Inc.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC